Logopharm announces launch of antibody products
Wednesday, 12 November 2008 16:24
As part of our proteomic studies and research collaborations, we have generated and thoroughly characterized a number of antibodies against membrane proteins and associated partners. A selected set – mostly affinity-purified polyclonal antibodies – will soon become commercially available by the end of 2008. Our antibodies are unique with respect to their quality and level of validation: specified applications like Westernblots, immunohistochemistry and affinity purification have been tested using native source-derived sample specimens, stringent controls including knockout samples or independent antibodies and quantitative mass spectrometry.
 
Meet Logopharm at BioEurope
Wednesday, 05 November 2008 12:04
Logopharm is attending this year's BioEurope international partnering conference in Mannheim (Nov 17-19, Germany). Don't miss the chance to meet us there, learn more about our technology and discuss potential opportunities.
 
Logopharm moves to new lab facility
Thursday, 19 June 2008 09:20
By July 2008 Logopharm will continue operations in a facility at the Gründerzentrum Freiburg. The new location offers more capacity and more direct access to infrastructure and collaborating laboratories. Consequently, our shipping address changes. Please see our contact page for details.
 
Logopharm initiates software development for mass spectrometry
Monday, 12 May 2008 15:51
To meet the increasing needs in bioinformatic processing of mass spectrometry data and to make full use of our proteomic capabilities, the company has decided to focus R&D efforts on development of novel tools for quantification and database integration. The new quantification software shall overcome current limitations of available tools and deliver reliable label-free protein quantification with high sensitivity and over a broad dynamic range. In a first step, it is planned to build a stand-alone version for evaluation of LC-MS/MS data from linear ion trap instruments. It will subsequently be developed into a commercial product and used to build up a proprietary membrane protein interaction database.
 
Ionenkanal-Superkomplexe - neue Proteinmaschinen der Neurobiologie
Monday, 08 January 2007 10:28
Freiburger Wissenschaftler klären die rätselhafte Verbindung von Kalzium- und Kaliumkanälen in Nervenzellen auf.
Read more...
 


Copyright 2010 Logopharm GmbH | Impressum | News-Feed
biotech pharma services | proteomics | membrane proteins | mass spectrometry | protein complexes | target research | biomarker research